Back to Insider Trading View Full Company Profile

KPTI

HEALTHY

Karyopharm Therapeutics Inc.

CIK: 0001503802

Sell (90% confidence)

Last activity: Mar 2, 2026

Financial Metrics

As of Dec 31, 2025 (10-K)

Net Income -$196.04M
Total Cash $155.97M
Current Ratio 2.09

Insider Roster (7 total, 7 active)

Insider Buys Sells Net Value Holdings
Paulson Richard A.
President and CEO
0 1 -$116K
267,030 shares
$2.51M
Poulton Stuart
EVP, Chief Development Officer
0 2 -$51K
94,328 shares
$888K
Rangwala Reshma
EVP & Chief Medical Officer
0 1 -$48K
56,739 shares
$534K
Cheng Sohanya Roshan
EVP & Chief Commercial Officer
0 1 -$43K
107,317 shares
$1.01M
Mano Michael
EVP, CLO&Secretary
0 1 -$33K
93,964 shares
$884K
Macomber Lori
EVP, CFO & Treasurer
0 1 -$10K
85,105 shares
$536K
Abate Kristin
Chief Accounting Officer
0 3 -$7K
22,063 shares
$208K

Recent Transactions

SELL Paulson Richard A. (President and CEO)

12,361 shares @ $9.41

$116K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Poulton Stuart (EVP, Chief Development Officer)

5,101 shares @ $9.41

$48K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Rangwala Reshma (EVP & Chief Medical Officer)

5,066 shares @ $9.41

$48K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Cheng Sohanya Roshan (EVP & Chief Commercial Officer)

4,604 shares @ $9.41

$43K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Mano Michael (EVP, CLO&Secretary)

3,526 shares @ $9.41

$33K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Abate Kristin (Chief Accounting Officer)

559 shares @ $9.41

$5K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Poulton Stuart (EVP, Chief Development Officer)

378 shares @ $8.63

$3K

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Macomber Lori (EVP, CFO & Treasurer)

1,626 shares @ $6.30

$10K

Feb 3, 2026

Conviction: | View SEC Filing →
SELL Abate Kristin (Chief Accounting Officer)

50 shares @ $7.03

$352

Jan 28, 2026

Conviction: | View SEC Filing →
SELL Abate Kristin (Chief Accounting Officer)

265 shares @ $5.96

$2K

Jan 21, 2026

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.